PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25789858-0	2015	Molecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeutics.	midostaurin	44-55	epidermal growth factor receptor	Homo sapiens	97-101	
25789858-13	2015	Molecular docking analysis revealed that the kinase inhibitor "midostaurin" has amongst the selected drug targets, the best ligand properties to S100A8 and EGFR, with the implication that its binding inhibits downstream signaling in KC.	midostaurin	63-74	epidermal growth factor receptor	Homo sapiens	156-160	
24189400-6	2013	With the use of a drug network associated with the core network proteins, we identified two compounds, midostaurin and lestaurtinib, that could overcome drug resistance through direct EGFR inhibition when combined with erlotinib.	midostaurin	103-114	epidermal growth factor receptor	Homo sapiens	184-188